Factor2 Multimedia Systems v. Regions Financial: Multifactor Authentication Patent Dispute Ends in Stipulated Dismissal
What would you like to do next?
Choose your path based on your current needs:
Introduction
A patent infringement dispute centered on multifactor authentication technology concluded with a negotiated exit rather than a courtroom decision. In Factor2 Multimedia Systems, LLC v. Regions Financial Corporation (Case No. 2:24-cv-00398), filed May 31, 2024, in the U.S. District Court for the Eastern District of Texas before Chief Judge Rodney Gilstrap, the parties reached a stipulated dismissal just over twelve months after the complaint was filed.
Factor2 asserted six patents covering authentication systems and apparatus against Regions Financial’s digital banking infrastructure. The case closed on June 10, 2025, with plaintiff’s claims dismissed with prejudice and defendant’s counterclaims dismissed without prejudice — a structured outcome that carries meaningful strategic implications for both patent assertion entities and financial sector defendants navigating authentication technology patent risk.
For patent attorneys, IP professionals, and R&D teams operating in the fintech and cybersecurity space, this case offers instructive lessons about venue selection, licensing negotiation leverage, and the procedural mechanics of multi-patent assertion campaigns.
📋 Case Summary
| Case Name | Factor2 Multimedia Systems, LLC v. Regions Financial Corporation |
| Case Number | 2:24-cv-00398 (E.D. Tex.) |
| Court | U.S. District Court for the Eastern District of Texas |
| Duration | May 31, 2024 – June 10, 2025 1 year 10 days |
| Outcome | Plaintiff Claims Dismissed WITH PREJUDICE |
| Patents at Issue | |
| Accused Products | Regions Financial’s digital banking system and apparatus |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity holding a portfolio of authentication-related patents. Operating as a non-practicing entity (NPE), Factor2 has pursued infringement claims across the financial services sector.
🛡️ Defendant
One of the largest full-service providers of consumer and commercial banking in the United States. Its digital banking platform was identified as the accused product.
The Patents at Issue
Factor2 asserted six U.S. patents, all directed at authentication technology. This portfolio reflects a deliberate continuation strategy, extending protection across multiple claim generations to maintain assertion leverage:
- • US8281129B1 — foundational authentication system claims
- • US9703938B2 — secure authentication apparatus
- • US9727864B2 — multimedia-based authentication systems
- • US9870453B2 — authentication method continuations
- • US10083285B2 — expanded authentication claim coverage
- • US10769297B2 — most recently issued; broadest continuation claims
The Accused Product
Regions Financial’s digital banking system and apparatus were identified as the infringing products. Authentication systems in modern banking — including login verification, identity confirmation, and secure transaction approval — represent the commercial embodiment of the asserted claims. The breadth of accused functionality made this a high-stakes assertion.
Litigation Timeline & Procedural History
| Milestone | Date |
| Complaint Filed | May 31, 2024 |
| Venue | E.D. Texas, Marshall Division |
| Presiding Judge | Chief Judge Rodney Gilstrap |
| Stipulated Motion for Dismissal Filed | Dkt. No. 45 |
| Case Closed | June 10, 2025 |
| Total Duration | 375 days |
The Eastern District of Texas remains a preferred venue for NPE plaintiffs due to its historically plaintiff-favorable procedures, experienced patent bench, and local patent rules that create early litigation structure. Chief Judge Rodney Gilstrap is among the most experienced patent judges in the federal judiciary, having presided over hundreds of patent cases and authoring significant claim construction decisions.
The 375-day duration — just over twelve months — suggests the parties engaged in substantive early-stage litigation, including likely exchange of contentions and preliminary claim construction proceedings, before reaching resolution. This timeline is consistent with pre-Markman settlement, a common inflection point in NPE-driven patent cases.
Implementing authentication tech?
Check if your system might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
Pursuant to the Stipulated Motion for Dismissal (Dkt. No. 45) and Federal Rule of Civil Procedure 41(a)(1)(ii), Chief Judge Gilstrap issued an order:
- • Dismissing all of Factor2’s claims WITH PREJUDICE — permanently barring Factor2 from re-asserting the same claims against Regions Financial on these patents
- • Dismissing Regions Financial’s counterclaims WITHOUT PREJUDICE — preserving Regions’ right to pursue invalidity or other counterclaims in future proceedings if warranted
- • Each party to bear its own costs, attorneys’ fees, and expenses
No damages award or injunctive relief was granted. The specific terms of any licensing agreement or financial consideration exchanged between the parties were not disclosed in the public record.
Verdict Cause Analysis
The case was initiated as a straightforward patent infringement action. The dismissal with prejudice of plaintiff’s claims — without an adjudicated finding on infringement or validity — strongly suggests the parties reached a confidential resolution, most likely a licensing agreement or lump-sum settlement. This is the standard resolution pathway for NPE-asserted, multi-patent portfolios against large financial institutions.
Key Legal Significance
Several legally notable dimensions emerge from this case structure:
- • Continuation Portfolio Assertion: Factor2’s use of six continuation patents across a family represents a sophisticated prosecution strategy. Continuation claims allow patent holders to capture evolving technology implementations using original priority dates. Courts and practitioners should note that defendants facing continuation portfolios often face compounding infringement exposure, making early resolution economically rational.
- • Counterclaim Preservation: Regions Financial’s decision to negotiate dismissal of its counterclaims without prejudice — rather than seeking adjudication — is a strategic hedge. If Factor2 asserts these patents against other Regions products or entities, Regions retains the right to challenge validity in a new proceeding. This approach avoids the collateral estoppel risks of a lost invalidity adjudication.
- • Rule 41(a)(1)(ii) Mechanics: The use of a stipulated dismissal under FRCP 41(a)(1)(ii) — rather than a settlement agreement entered as a court order — keeps financial terms confidential. Practitioners should note this as the standard vehicle for resolving NPE cases where licensing terms are commercially sensitive.
Strategic Takeaways
- • For Patent Holders (NPEs and Operating Companies): Continuation portfolio strategies maximize assertion leverage. Filing in the Eastern District of Texas before Judge Gilstrap signals litigation seriousness to defendants, accelerating licensing discussions. Securing a with-prejudice dismissal from plaintiff’s side confirms resolution — protecting the licensing arrangement from further litigation.
- • For Accused Infringers (Financial Institutions and Technology Companies): Early engagement with McGuireWoods-style IP defense counsel — experienced in both patent litigation and financial services — is essential. Preserving counterclaim rights without prejudice upon settlement is a negotiation priority. Consider parallel IPR petitions at the USPTO to strengthen invalidity positions and reduce settlement leverage held by plaintiff.
- • For R&D Teams: Authentication technology remains a high-risk patent assertion target. Freedom-to-operate (FTO) analyses should specifically address multifactor authentication implementations, continuation patent families, and any overlap with the Factor2 portfolio patents cited above.
Drafting authentication patents?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in multifactor authentication. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all 6+ patents in the Factor2 portfolio
- See which companies are most active in authentication patents
- Understand continuation claim strategy patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Multifactor Authentication Systems
6+ Asserted Patents
From Factor2 continuation family
Design-Around Options
Potential for many claims
Industry & Competitive Implications
The authentication technology patent space — encompassing multifactor authentication (MFA), biometric verification, and secure transaction systems — is among the most actively litigated technology areas in financial services IP. The Factor2 portfolio reflects a broader industry pattern: NPEs acquiring foundational authentication patents and systematically asserting them against financial institutions whose digital banking platforms implement commercially equivalent functionality.
For the banking sector, this case underscores the necessity of proactive patent portfolio monitoring and pre-litigation FTO analysis. Regions Financial’s engagement of McGuireWoods and its preservation of counterclaim rights demonstrates best-in-class institutional IP defense strategy.
The resolution also reflects an industry-wide trend toward pre-trial settlement in NPE-driven patent assertions, particularly where continuation portfolios create multi-claim exposure and litigation costs exceed negotiated licensing fees. According to broader patent litigation data, over 85% of district court patent cases resolve before trial — this case is consistent with that pattern.
Companies in fintech, banking technology, and enterprise security should audit their authentication implementations against the Factor2 patent family and evaluate IPR petition strategies as a proactive risk mitigation measure.
✅ Key Takeaways
For Patent Attorneys & Litigators
Stipulated dismissal with prejudice (plaintiff) / without prejudice (defendant) is a sophisticated asymmetric resolution protecting strategic interests.
Search related case law →Factor2’s six-patent continuation strategy illustrates effective portfolio construction for licensing leverage.
Explore precedents →E.D. Texas before Chief Judge Gilstrap remains a high-signal plaintiff-favorable venue choice.
View E.D. Tex statistics →For IP Professionals
Monitor continuation patent families in authentication technology for downstream assertion risk.
Start FTO analysis for my product →Preserve IPR petition rights at USPTO as a hedge even after litigation resolution.
Explore IPR options →Confidential resolution terms under FRCP 41(a)(1)(ii) remain standard for NPE licensing outcomes.
Understand FRCP 41 →For R&D Teams
Multifactor authentication systems are prime assertion targets — initiate FTO review against US8281129B1, US10769297B2, and related Factor2 family patents.
Start FTO analysis for my product →Design-around analysis should address continuation claim scope, not just issued independent claims.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your product’s freedom to operate now.
Run FTO for My Product⚡ Accelerate Your IP Strategy
Join 15,000+ IP professionals using PatSnap Eureka for patent research and analysis.